User profiles for Benjamin S. Glicksberg
Benjamin GlicksbergVP Data Science & Machine Learning, Character Biosciences | Adjunct Professor, Icahn�… Verified email at mssm.edu Cited by 15951 |
Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19
Please note: This work was supported by U54 TR001433-05, National Center for Advancing
Translational Sciences, National Institutes of Health. Dr. Fayad has received consulting fees …
Translational Sciences, National Institutes of Health. Dr. Fayad has received consulting fees …
[HTML][HTML] Federated learning for healthcare informatics
With the rapid development of computer software and hardware technologies, more and
more healthcare data are becoming readily available from clinical institutions, patients, …
more healthcare data are becoming readily available from clinical institutions, patients, …
Artificial intelligence in cardiology
Artificial intelligence and machine learning are poised to influence nearly every aspect of
the human condition, and cardiology is not an exception to this trend. This paper provides a …
the human condition, and cardiology is not an exception to this trend. This paper provides a …
Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection
…, A Charney, E Bagiella, J Narula, BS Glicksberg…�- Journal of the American�…, 2020 - jacc.org
Background The degree of myocardial injury, as reflected by troponin elevation, and
associated outcomes among US hospitalized patients with coronavirus disease-2019 (COVID-19) …
associated outcomes among US hospitalized patients with coronavirus disease-2019 (COVID-19) …
[HTML][HTML] AKI in hospitalized patients with COVID-19
…, EP B�ttinger, BS Glicksberg…�- Journal of the�…, 2021 - journals.lww.com
Background Early reports indicate that AKI is common among patients with coronavirus
disease 2019 (COVID-19) and associated with worse outcomes. However, AKI among …
disease 2019 (COVID-19) and associated with worse outcomes. However, AKI among …
Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19
…, AS Dunn, ME Farkouh, BS Glicksberg…�- Journal of the American�…, 2020 - jacc.org
Background Thromboembolic disease is common in coronavirus disease-2019 (COVID-19).
There is limited evidence on the association of in-hospital anticoagulation (AC) with …
There is limited evidence on the association of in-hospital anticoagulation (AC) with …
Coronavirus 2019 and people living with human immunodeficiency virus: outcomes for hospitalized patients in New York City
…, A Charney, G Nadkarni, BS Glicksberg�- Clinical infectious�…, 2020 - academic.oup.com
Background There are limited data regarding the clinical impact of coronavirus disease 2019
(COVID-19) on people living with human immunodeficiency virus (PLWH). In this study, we …
(COVID-19) on people living with human immunodeficiency virus (PLWH). In this study, we …
Identification of type 2 diabetes subgroups through topological analysis of patient similarity
L Li, WY Cheng, BS Glicksberg, O Gottesman…�- Science translational�…, 2015 - science.org
Type 2 diabetes (T2D) is a heterogeneous complex disease affecting more than 29 million
Americans alone with a rising prevalence trending toward steady increases in the coming …
Americans alone with a rising prevalence trending toward steady increases in the coming …
[HTML][HTML] SARS-CoV-2 viral load predicts COVID-19 mortality
…, A Wajnberg, G Nadkarni, BS Glicksberg…�- The Lancet�…, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection platforms currently
report qualitative results. However, technology based on RT-PCR allows for calculation of …
report qualitative results. However, technology based on RT-PCR allows for calculation of …
[HTML][HTML] Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Understanding the pathophysiology of SARS-CoV-2 infection is critical for therapeutic and
public health strategies. Viral–host interactions can guide discovery of disease regulators, …
public health strategies. Viral–host interactions can guide discovery of disease regulators, …